Form 8-K PACIFIC BIOSCIENCES OF For: Jul 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Pacific Biosciences of California, Inc. (PACB) Tops Q1 EPS by 1c
July 24, 2014 4:28 PM EDTPacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q1 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.39 thousand.
For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.
... More